Diuril (Chlorothiazide Suspension) and Hydrocodone and homatropine
Determining the interaction of Diuril (Chlorothiazide Suspension) and Hydrocodone and homatropine and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Chlorothiazide and HYDROcodone may have additive effects in lowering your blood pressure. You may experience headache, dizziness, lightheadedness, fainting, and/or changes in pulse or heart rate. These side effects are most likely to be seen at the beginning of treatment, following a dose increase, or when treatment is restarted after an interruption. Let your doctor know if you develop these symptoms and they do not go away after a few days or they become troublesome. Avoid driving or operating hazardous machinery until you know how the medications affect you, and use caution when getting up from a sitting or lying position. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation. Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.
MANAGEMENT: Caution is advised during coadministration of these agents. Close monitoring for development of hypotension is recommended. Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.
- Feder R "Bradycardia and syncope induced by fluoxetine." J Clin Psychiatry 52 (1991): 139
- Ellison JM, Milofsky JE, Ely E "Fluoxetine-induced bradycardia and syncope in two patients." J Clin Psychiatry 51 (1990): 385-6
- Sternbach H "Fluoxetine-associated potentiation of calcium-channel blockers." J Clin Psychopharmacol 11 (1991): 390-1
- Rodriguez de la Torre B, Dreher J, Malevany I, et al. "Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients." Ther Drug Monit 23 (2001): 435-40
- Pacher P, Kecskemeti V "Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?" Curr Pharm Des 10 (2004): 2463-75
- Andrews C, Pinner G "Postural hypotension induced by paroxetine." BMJ 316 (1998): 595
Generic Name: chlorothiazide
Brand name: Diuril, Diuril Sodium
Synonyms: Diuril (oral/injection), Diuril
Generic Name: homatropine / hydrocodone
Brand name: Hydromet, Tussigon, Hycodan, Hydrotropine, Hydromide, Hydropane
Synonyms: Homatropine and hydrocodone, Hydrocodone and Homatropine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Diuril (Chlorothiazide Suspension)-Hydrocodone and Homatropine Syrup
- Diuril (Chlorothiazide Suspension)-Hydrocodone and Homatropine Tablets
- Diuril (Chlorothiazide Suspension)-Hydrocodone and ibuprofen
- Diuril (Chlorothiazide Suspension)-Hydrocodone and Pseudoephedrine
- Diuril (Chlorothiazide Suspension)-Hydrocodone Bitartrate
- Diuril (Chlorothiazide Suspension)-Hydrocodone Bitartrate and Acetaminophen Oral Solution
- Hydrocodone and homatropine-Diuril Injection
- Hydrocodone and homatropine-Diuril oral/injection
- Hydrocodone and homatropine-Diuril Sodium
- Hydrocodone and homatropine-Divalproex
- Hydrocodone and homatropine-Divalproex Capsules
- Hydrocodone and homatropine-Divalproex Delayed Release